Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1766812
PUBLISHER: GlobalData | PRODUCT CODE: 1766812
United States Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests
PUBLISHED:
PAGES: 36 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "United States Metabolic Disorders Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Diabetes Assays and Cholesterol Tests
The United States Metabolic Disorders Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2024 company share data for Metabolic Disorders Market.
- Global corporate-level profiles of key companies operating within the United States Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Metabolic Disorders is segmented as follows -
- Diabetes Assays
- Cholesterol Tests
Reasons to Buy
The United States Metabolic Disorders Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME25615CCDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Metabolic Disorders Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Metabolic Disorders Market, United States
- 3.1 Metabolic Disorders Market, United States, Revenue ($m), 2018-2033
- 3.1.1 Cholesterol Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Diabetes Assays Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.2 Metabolic Disorders Market, United States, Volume (Units), 2018-2033
- 3.2.1 Cholesterol Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.2 Diabetes Assays Market, United States, Volume (Units), by Segment, 2018-2033
- 3.3 Metabolic Disorders Market, United States, Average Price ($), 2018-2033
- 3.4 Metabolic Disorders Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Metabolic Disorders Market
- 4.1 Abbott Laboratories
- 4.1.1 Company Overview
- 4.2 Siemens Healthineers AG
- 4.2.1 Company Overview
- 4.3 Beckman Coulter Inc
- 4.3.1 Company Overview
- 4.4 Ortho Clinical Diagnostics Holdings Plc
- 4.4.1 Company Overview
- 4.5 Roche Diagnostics International Ltd
- 4.5.1 Company Overview
- 4.6 Bio-Rad Laboratories Inc
- 4.6.1 Company Overview
5 Metabolic Disorders Market Pipeline Products
6 Recent Developments
- 6.1 Product News
- 6.1.1 May 21, 2025: MedImpact Unveils MedEmpower Fuel AI Plate Scanner
- 6.1.2 Mar 21, 2025: Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
- 6.1.3 Jan 06, 2025: Introducing isaac by PreEvnt - Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit
- 6.2 Strategy And Business Planning
- 6.2.1 Jul 17, 2024: New Opportunity to Improve Diagnosis Care for People with Cardiovascular-Kidney-Metabolic Syndrome
7 Appendix
- 7.1 Research Methodology
- 7.1.1 Coverage
- 7.1.2 Secondary Research
- 7.1.3 Primary Research
- 7.1.4 Market Modeling and Forecasting
- 7.1.5 Company Share Analysis
- 7.1.6 Benchmarking
- 7.2 GlobalData Consulting
- 7.3 Contact Us
- 7.4 Disclaimer
Product Code: GDME25615CCDB
List of Table
List of Tables
- Table 1: Metabolic Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 2: Cholesterol Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 3: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 4: Metabolic Disorders Market, United States, Volume (Units), 2018-2033
- Table 5: Cholesterol Tests Market, United States, Volume (Units), 2018-2033
- Table 6: Diabetes Assays Market, United States, Volume (Units), 2018-2033
- Table 7: Metabolic Disorders Market, United States, Average Price ($), 2018-2033
- Table 8: Metabolic Disorders Market, United States, Company Share by Revenue ($m), 2024
- Table 9: Metabolic Disorders Market Pipeline Products
- Table 10: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figure
List of Figures
- Figure 1: Metabolic Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Cholesterol Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Metabolic Disorders Market, United States, Volume (Units), 2018-2033
- Figure 5: Cholesterol Tests Market, United States, Volume (Units), 2018-2033
- Figure 6: Diabetes Assays Market, United States, Volume (Units), 2018-2033
- Figure 7: Metabolic Disorders Market, United States, Company Share (%), 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.